Investing Profile

Mark McDade

VCInvestorFounder
Co-Founder and Partner at Qiming Venture Partners USA
qimingvcusa.comSeattle, Washington
Photo of Mark McDade, Partner at Qiming Venture Partners USA
Your Intro Paths to Mark McDade
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Networks Mark is a member of
Harvard Business School Network
424 CONNECTIONS
Dartmouth College Network
80 CONNECTIONS

Find Mark McDade on

cb
Current Investing Position
Qiming Venture Partners USA Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
7
Current Fund Size
$6.2B

Mark McDade is on these Sector & Stage Rankings

Mark McDade's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Icosavax
Series BApr 2021$100M
Series AOct 2019$51M
$150M
Co-investors: Peter Kolchinsky (RA Capital)
Platelet BioGenesis
Series ASep 2019$26M
$26M
Talaris Therapeutics
Series AApr 2019$100M
$100M
WindMIL Therapeutics
Series BJun 2018$33M
$33M
Twine Health
Series AMay 2017$2M
$2M
ZappRx
Series BApr 2017$25M
$40M
Co-investors: Jens Eckstein (Apollo Health Ventures), Wayne Chang

Mark McDade's Experience

Co Founder and Partner Qiming Venture Partners USA2017 - Present
EVP and Chief Operating Officer UCB2008 - 2016
CEO PDL BioPharma2002 - 2007
Chief Executive Officer Signature BioScience2001 - 2002
Co-founder and COO Corixa Corporation1994 - 2000
COO Boehringer Mannheim Therapeutics1992 - 1994

Mark McDade's Education

Harvard Business School
Dartmouth College Bachelor of Arts (B.A.) History